The 5-HT1B/D agonist sumatriptan selectively enhances IA in a concentration-dependent manner.
The 5-HT1D, but not 5-HT1B, induces IA increase in small-sized TG neurons.
The Gβγ-dependent protein kinase A is required in the 5-HT1D-mediated response.
The 5-HT1D-mediated IA increase requires B-Raf-dependent p38 MAPK signaling.
5-HT1D decreases membrane excitability of TG neurons.